NCT04954859 - Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) | Biotech Hunter

Enrollment

450

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

February 8, 2029

Study Completion Date

February 8, 2029

Conditions

Hepatitis B

Interventions

DRUG

Bepirovirsen

No study drug will be administered in this study. Eligible participants who received prior treatment with bepirovirsen in the parent studies will be included.

DRUG

Placebo

No study drug will be administered in this study. Eligible participants who received prior treatment with placebo in the parent studies (209668, 202009, and 219288) will be included to maintain the blind in the still ongoing parent studies.

Trial Locations (51)

1431

RECRUITING

GSK Investigational Site, Sofia

1830

RECRUITING

GSK Investigational Site, Johannesburg

4091

RECRUITING

GSK Investigational Site, Durban

8800

RECRUITING

GSK Investigational Site, Sliven

10400

RECRUITING

GSK Investigational Site, Bangkok

15355

RECRUITING

GSK Investigational Site, Ansan-si Gyenggi-do

20081

RECRUITING

GSK Investigational Site, Lublin

20122

RECRUITING

GSK Investigational Site, Milan

20157

RECRUITING

GSK Investigational Site, Milan

28031

RECRUITING

GSK Investigational Site, Madrid

39008

RECRUITING

GSK Investigational Site, Santander

40126

RECRUITING

GSK Investigational Site, Modena

47392

RECRUITING

GSK Investigational Site, Busan

48202

RECRUITING

GSK Investigational Site, Detroit

49241

RECRUITING

GSK Investigational Site, Pusan

67200

RECRUITING

GSK Investigational Site, Strasbourg

90110

RECRUITING

GSK Investigational Site, Kho Hong Hat Yai

92110

RECRUITING

GSK Investigational Site, Clichy

95817

RECRUITING

GSK Investigational Site, Sacramento

119074

RECRUITING

GSK Investigational Site, Singapore

121170

RECRUITING

GSK Investigational Site, Moscow

190103

RECRUITING

GSK Investigational Site, Saint Petersburg

191167

RECRUITING

GSK Investigational Site, Saint Petersburg

200025

RECRUITING

GSK Investigational Site, Shanghai

310000

RECRUITING

GSK Investigational Site, Hangzhou

417307

RECRUITING

GSK Investigational Site, Craiova Dolj

430030

RECRUITING

GSK Investigational Site, Wuhan

443063

RECRUITING

GSK Investigational Site, Samara

454052

RECRUITING

GSK Investigational Site, Chelyabinsk

529889

RECRUITING

GSK Investigational Site, Singapore

630099

RECRUITING

GSK Investigational Site, Novosibirsk

660049

RECRUITING

GSK Investigational Site, Красноярск

800179

RECRUITING

GSK Investigational Site, Galati

02114

RECRUITING

GSK Investigational Site, Boston

C1181ACH

RECRUITING

GSK Investigational Site, Buenos Aires

T2N 4Z6

RECRUITING

GSK Investigational Site, Calgary

V8R 6R3

RECRUITING

GSK Investigational Site, Victoria

M5G 2C4

RECRUITING

GSK Investigational Site, Toronto

Unknown

RECRUITING

GSK Investigational Site, Pokfulam

730-8619

RECRUITING

GSK Investigational Site, Hiroshima

734-8551

RECRUITING

GSK Investigational Site, Hiroshima

920-8650

RECRUITING

GSK Investigational Site, Ishikawa

760-8557

RECRUITING

GSK Investigational Site, Kagawa

862-8655

RECRUITING

GSK Investigational Site, Kumamoto

980-8574

RECRUITING

GSK Investigational Site, Miyagi

565-0871

RECRUITING

GSK Investigational Site, Osaka

113-8603

RECRUITING

GSK Investigational Site, Tokyo

180-8610

RECRUITING

GSK Investigational Site, Tokyo

05505

RECRUITING

GSK Investigational Site, Seoul

WC1E 6JB

RECRUITING

GSK Investigational Site, London

PL68DH

RECRUITING

GSK Investigational Site, Plymouth